Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis - PubMed (original) (raw)
Review
Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis
A C Jones et al. Am J Hum Genet. 1999 May.
Abstract
Tuberous sclerosis (TSC [MIM 191090 and MIM 191100]) is an autosomal dominant disorder characterized by hamartomas in many organs. Two thirds of cases are sporadic and are thought to represent new mutations. TSC is caused by mutations affecting either of the presumed tumor-suppressor genes, TSC1 and TSC2. Both appear to function as tumor suppressors, because somatic loss or intragenic mutation of the corresponding wild-type allele is seen in the associated hamartomas. Here we report the first comprehensive mutation analysis of TSC1 and TSC2 in a cohort of 150 unrelated TSC patients and their families, using heteroduplex and SSCP analysis of all coding exons and using pulsed-field gel electrophoresis and conventional Southern blot analysis and long PCR to screen for large rearrangements. Mutations were characterized in 120 (80%) of the 150 cases, affecting TSC1 in 22 cases and TSC2 in 98 cases. TSC1 mutations were significantly underrepresented in sporadic cases (P=. 000185). Twenty-two patients had TSC2 missense mutations that were found predominantly in the GAP-related domain (eight cases) and in a small region encoded in exons 16 and 17, between nucleotides 1849 and 1859 (eight cases), consistent with the presence of residues performing key functions at these sites. In contrast, all TSC1 mutations were predicted to be truncating, consistent with a structural or adapter role for the encoded protein. Intellectual disability was significantly more frequent in TSC2 sporadic cases than in TSC1 sporadic cases (P=.0145). These data provide the first representative picture of the distribution and spectrum of mutations across the TSC1 and TSC2 loci in clinically ascertained TSC and support a difference in severity of TSC1- and TSC2-associated disease.
Similar articles
- Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D, Kwiatkowski DJ. Dabora SL, et al. Am J Hum Genet. 2001 Jan;68(1):64-80. doi: 10.1086/316951. Epub 2000 Dec 8. Am J Hum Genet. 2001. PMID: 11112665 Free PMC article. - Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
Niida Y, Lawrence-Smith N, Banwell A, Hammer E, Lewis J, Beauchamp RL, Sims K, Ramesh V, Ozelius L. Niida Y, et al. Hum Mutat. 1999;14(5):412-22. doi: 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K. Hum Mutat. 1999. PMID: 10533067 - Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, Sampson JR, Cheadle JP. Jones AC, et al. Hum Mol Genet. 1997 Nov;6(12):2155-61. doi: 10.1093/hmg/6.12.2155. Hum Mol Genet. 1997. PMID: 9328481 - Aspects of tuberous sclerosis complex (TSC) protein function in the brain.
Ramesh V. Ramesh V. Biochem Soc Trans. 2003 Jun;31(Pt 3):579-83. doi: 10.1042/bst0310579. Biochem Soc Trans. 2003. PMID: 12773159 Review. - Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours.
Knowles MA, Hornigold N, Pitt E. Knowles MA, et al. Biochem Soc Trans. 2003 Jun;31(Pt 3):597-602. doi: 10.1042/bst0310597. Biochem Soc Trans. 2003. PMID: 12773163 Review.
Cited by
- Experience of the first adult-focussed undiagnosed disease program in Australia (AHA-UDP): solving rare and puzzling genetic disorders is ageless.
Wallis M, Bodek SD, Munro J, Rafehi H, Bennett MF, Ye Z, Schneider A, Gardiner F, Valente G, Murdoch E, Uebergang E, Hunter J, Stutterd C, Huq A, Salmon L, Scheffer I, Eratne D, Meyn S, Fong CY, John T, Mullen S, White SM, Brown NJ, McGillivray G, Chen J, Richmond C, Hughes A, Krzesinski E, Fennell A, Chambers B, Santoreneos R, Le Fevre A, Hildebrand MS, Bahlo M, Christodoulou J, Delatycki M, Berkovic SF. Wallis M, et al. Orphanet J Rare Dis. 2024 Aug 2;19(1):288. doi: 10.1186/s13023-024-03297-5. Orphanet J Rare Dis. 2024. PMID: 39095811 Free PMC article. - Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.
Liu C, Lele SM, Goodenberger MH, Reiser GM, Christiansen AJ, Padussis JC. Liu C, et al. BMC Med Genomics. 2024 May 27;17(1):144. doi: 10.1186/s12920-024-01913-8. BMC Med Genomics. 2024. PMID: 38802873 Free PMC article. Review. - Review of the spectrum of tuberous sclerosis complex: The Saudi Arabian Experience.
Almuqbil M, Aldoohan W, Alhinti S, Almahmoud N, Abdulmajeed I, Alkhodair R, Kashgari A, Baarmah D, Altwaijri W, Alrumayyan A. Almuqbil M, et al. Neurosciences (Riyadh). 2024 May;29(2):113-121. doi: 10.17712/nsj.2024.2.20230061. Neurosciences (Riyadh). 2024. PMID: 38740395 Free PMC article. - Neurocutaneous Diseases: Diagnosis, Management, and Treatment.
Kioutchoukova I, Foster D, Thakkar R, Ciesla C, Cabassa JS, Strouse J, Kurz H, Lucke-Wold B. Kioutchoukova I, et al. J Clin Med. 2024 Mar 13;13(6):1648. doi: 10.3390/jcm13061648. J Clin Med. 2024. PMID: 38541874 Free PMC article. Review. - Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus.
Shimoda K, Iwasaki H, Mizuno Y, Seki M, Mimaki M, Kato M, Shinozaki-Ushiku A, Mori H, Ogawa S, Mizuguchi M. Shimoda K, et al. Front Pediatr. 2024 Feb 21;12:1333064. doi: 10.3389/fped.2024.1333064. eCollection 2024. Front Pediatr. 2024. PMID: 38455392 Free PMC article.
References
- Hum Mol Genet. 1995 Dec;4(12):2295-8 - PubMed
- Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3 - PubMed
- J Med Genet. 1989 Jan;26(1):28-31 - PubMed
- Cell. 1991 Mar 8;64(5):915-25 - PubMed
- Ann N Y Acad Sci. 1991;615:125-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous